Micro Cap Growth Fund
Daily price w/o sales charge as of 09/30/2020
$17.41
$0.04
YTD Returns w/o sales charge as of 09/30/2020
31.30%
Overall Morningstar RatingsSmall Growth
as of 08/31/2020
Morningstar rated the Lord Abbett Micro Cap Growth Fund class A share 4, 4 and 5 stars among 577, 512 and 382 Small Growth Funds for the overall rating and the 3, 5 and 10 year periods ended 8/31/2020, respectively.
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of micro and small-sized U.S. companies.
Fund Basicsas of 08/31/2020
- Total Net Assets
- $100.15 M
- Inception Date
- 05/01/2000
- Dividend Frequency
- Annually
- Fund Expense Ratio
- 1.31%
- Number of Holdings
- 90
- Minimum Initial Investment
- $1,500+
Fund Expense Ratio :
1.31%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 31.30% | 55.68% | 23.35% | 20.75% | 18.52% | 10.92% |
| Lipper Category Avg. Small-Cap Growth Funds | - | - | - | - | - | - |
| Russell Microcap® Growth Index | - | - | - | - | - | - |
| w/ sales charge | 23.74% | 46.68% | 20.93% | 19.33% | 17.82% | 10.60% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
1.31%
Fund Expense Ratio :
1.31%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 31.30% | 55.68% | 23.35% | 20.75% | 18.52% | 10.92% |
| Lipper Category Avg. Small-Cap Growth Funds | - | - | - | - | - | - |
| Russell Microcap® Growth Index | - | - | - | - | - | - |
| w/ sales charge | 23.74% | 46.68% | 20.93% | 19.33% | 17.82% | 10.60% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
1.31%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 08/31/2020View Portfolio
| Holding | Assets |
|---|---|
| Fiverr International Ltd | 2.7% |
| Silk Road Medical Inc | 2.7% |
| Cerence Inc | 2.6% |
| Calix Networks, Inc. | 2.2% |
| LGI Homes, Inc. | 2.2% |
| Malibu Boats, Inc. | 2.1% |
| Twist Bioscience Corp | 2.1% |
| Axonics Modulation Technologies Inc | 2.0% |
| TG Therapeutics, Inc. | 2.0% |
| Inspire Medical Systems Inc | 1.9% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 08/31/2020View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Not Classified | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
1.31%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 31.30% | 55.68% | 23.35% | 20.75% | 18.52% | 10.92% |
| Lipper Category Avg. Small-Cap Growth Funds | - | - | - | - | - | - |
| Russell Microcap® Growth Index | - | - | - | - | - | - |
| w/ sales charge | 23.74% | 46.68% | 20.93% | 19.33% | 17.82% | 10.60% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
1.31%
Fund Expense Ratio :
1.31%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 31.30% | 55.68% | 23.35% | 20.75% | 18.52% | 10.92% |
| Lipper Category Avg. Small-Cap Growth Funds | - | - | - | - | - | - |
| Russell Microcap® Growth Index | - | - | - | - | - | - |
| w/ sales charge | 23.74% | 46.68% | 20.93% | 19.33% | 17.82% | 10.60% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
1.31%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
| Year | Fund Returns | Russell Microcap® Growth Index |
|---|
| 2019 | 34.57% | 23.33% |
| 2018 | 2.74% | -14.18% |
| 2017 | 38.43% | 16.65% |
| 2016 | 2.07% | 6.86% |
| 2015 | -6.38% | -3.85% |
| 2014 | 10.83% | 4.30% |
| 2013 | 78.53% | 52.84% |
| 2012 | 2.35% | 15.17% |
| 2011 | -5.87% | -8.42% |
| 2010 | 33.77% | 29.48% |
| 2009 | 52.61% | - |
| 2008 | -46.45% | - |
| 2007 | 22.76% | - |
| 2006 | 25.37% | - |
| 2005 | 2.55% | - |
| 2004 | 25.89% | - |
| 2003 | 49.34% | - |
| 2002 | -30.97% | - |
| 2001 | 16.96% | - |
| 2000 | -30.76% | - |
| Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
|---|
| 2020 | -24.28% | 47.61% | 17.48% | - | 31.30% |
| 2019 | 22.67% | 7.47% | -13.91% | 18.57% | 34.57% |
| 2018 | 5.24% | 15.77% | 10.08% | -23.39% | 2.74% |
| 2017 | 9.00% | 8.12% | 13.61% | 3.39% | 38.43% |
| 2016 | -13.70% | 6.01% | 14.49% | -2.55% | 2.07% |
| 2015 | 7.33% | 4.15% | -16.30% | 0.06% | -6.38% |
| 2014 | 7.92% | -6.53% | -6.55% | 17.58% | 10.83% |
| 2013 | 21.83% | 15.00% | 17.29% | 8.65% | 78.53% |
| 2012 | 17.67% | -9.76% | 1.32% | -4.87% | 2.35% |
| 2011 | 4.82% | 0.11% | -21.90% | 14.86% | -5.87% |
| 2010 | 6.60% | -8.74% | 15.08% | 19.49% | 33.77% |
| 2009 | -0.95% | 31.46% | 13.47% | 3.29% | 52.61% |
| 2008 | -23.22% | 4.46% | -5.93% | -29.02% | -46.45% |
| 2007 | 5.64% | 9.81% | 4.01% | 1.76% | 22.76% |
| 2006 | 17.15% | -9.83% | 1.22% | 17.25% | 25.37% |
| 2005 | -9.50% | 5.88% | 6.91% | 0.10% | 2.55% |
| 2004 | 12.33% | 1.65% | -11.11% | 24.03% | 25.89% |
| 2003 | -3.55% | 27.29% | 11.68% | 8.93% | 49.34% |
| 2002 | -0.18% | -12.74% | -21.79% | 1.33% | -30.97% |
| 2001 | 2.34% | 12.03% | -21.11% | 29.32% | 16.96% |
| 2000 | - | - | -4.83% | -19.30% | -30.76% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 08/31/2020
The chart begins on the Fund's inception date of 05/01/2000.
Based on a hypothetical Class A share investment of $10,000 on 05/01/2000 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Fiverr International Ltd | Consumer Discretionary | 2.7% |
| Silk Road Medical Inc | Health Care | 2.7% |
| Cerence Inc | Information Technology | 2.6% |
| Calix Networks, Inc. | Information Technology | 2.2% |
| LGI Homes, Inc. | Consumer Discretionary | 2.2% |
| Malibu Boats, Inc. | Consumer Discretionary | 2.1% |
| Twist Bioscience Corp | Health Care | 2.1% |
| Axonics Modulation Technologies Inc | Health Care | 2.0% |
| TG Therapeutics, Inc. | Health Care | 2.0% |
| Inspire Medical Systems Inc | Health Care | 1.9% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Fiverr International Ltd | Consumer Discretionary | 2.7% |
| Silk Road Medical Inc | Health Care | 2.7% |
| Cerence Inc | Information Technology | 2.6% |
| LGI Homes, Inc. | Consumer Discretionary | 2.2% |
| Calix Networks, Inc. | Information Technology | 2.2% |
| Twist Bioscience Corp | Health Care | 2.1% |
| Malibu Boats, Inc. | Consumer Discretionary | 2.1% |
| TG Therapeutics, Inc. | Health Care | 2.0% |
| Axonics Modulation Technologies Inc | Health Care | 2.0% |
| Inspire Medical Systems Inc | Health Care | 1.9% |
| Sprout Social Inc | Information Technology | 1.9% |
| CryoPort Inc | Health Care | 1.9% |
| Vivint Solar, Inc. | Industrials | 1.9% |
| Shockwave Medical Inc | Health Care | 1.7% |
| Chart Industries, Inc. | Industrials | 1.7% |
| Select Comfort Corp. | Consumer Discretionary | 1.7% |
| OrthoPediatrics Corp | Health Care | 1.7% |
| Limelight Networks, Inc. | Information Technology | 1.7% |
| elf Beauty, Inc. | Consumer Staples | 1.6% |
| CEVA, Inc. | Information Technology | 1.6% |
| Trupanion Inc | Financials | 1.6% |
| Quanterix Corp | Health Care | 1.5% |
| Myovant Sciences Ltd | Health Care | 1.5% |
| Digital Turbine Inc | Information Technology | 1.4% |
| Turning Point Therapeutics Inc | Health Care | 1.3% |
| Rocket Pharmaceuticals Inc | Health Care | 1.3% |
| Montrose Environmental Group Inc | Industrials | 1.3% |
| Goosehead Insurance Inc | Financials | 1.3% |
| Evoqua Water Technologies Corp | Industrials | 1.2% |
| NanoString Technologies, Inc. | Health Care | 1.2% |
| Papa John's International, Inc. | Consumer Discretionary | 1.2% |
| Ichor Holdings Ltd | Information Technology | 1.2% |
| Ontrak Inc | Health Care | 1.1% |
| Vital Farms Inc | Consumer Staples | 1.1% |
| Spartan Motors, Inc. | Industrials | 1.1% |
| GenMark Diagnostics, Inc. | Health Care | 1.1% |
| Inari Medical Inc | Health Care | 1.0% |
| iRhythm Technologies, Inc. | Health Care | 1.0% |
| SPX Corp. | Industrials | 1.0% |
| Crocs, Inc. | Consumer Discretionary | 1.0% |
| 1-800-Flowers.com, Inc. | Consumer Discretionary | 1.0% |
| RealReal Inc/The | Consumer Discretionary | 1.0% |
| Cardlytics Inc | Information Technology | 1.0% |
| Agilysys Inc | Information Technology | 1.0% |
| nLight Inc | Information Technology | 0.9% |
| Overstock.com, Inc. | Consumer Discretionary | 0.9% |
| Veracyte Inc | Health Care | 0.9% |
| Castle Biosciences Inc | Health Care | 0.9% |
| Upland Software Inc | Information Technology | 0.9% |
| Federal Signal Corp. | Industrials | 0.8% |
| Insmed, Inc. | Health Care | 0.8% |
| Aerovironment, Inc. | Industrials | 0.8% |
| Redfin Corp | Real Estate | 0.8% |
| Rambus, Inc. | Information Technology | 0.8% |
| Eidos Therapeutics Inc | Health Care | 0.8% |
| Simulations Plus Inc | Health Care | 0.8% |
| Ameresco, Inc. | Industrials | 0.8% |
| Krystal Biotech Inc | Health Care | 0.8% |
| National Vision Holdings Inc | Consumer Discretionary | 0.8% |
| Stamps.com, Inc. | Consumer Discretionary | 0.8% |
| Aurinia Pharmaceuticals Inc | Health Care | 0.8% |
| Sonos Inc | Consumer Discretionary | 0.8% |
| Adaptimmune Therapeutics plc | Health Care | 0.8% |
| Karuna Therapeutics Inc | Health Care | 0.8% |
| Health Catalyst Inc | Health Care | 0.7% |
| The Rubicon Project, Inc. | Consumer Discretionary | 0.7% |
| Endava PLC | Information Technology | 0.7% |
| Pliant Therapeutics Inc | Health Care | 0.7% |
| Denali Therapeutics Inc | Health Care | 0.7% |
| Seres Therapeutics, Inc. | Health Care | 0.6% |
| AudioCodes Ltd | Information Technology | 0.6% |
| Rapid7, Inc. | Information Technology | 0.6% |
| Beam Therapeutics Inc | Health Care | 0.6% |
| Black Diamond Therapeutics Inc | Health Care | 0.6% |
| Insurance Acquisition Corp | Undefined | 0.6% |
| SVMK Inc | Information Technology | 0.5% |
| Wrap Technologies Inc | Information Technology | 0.5% |
| Landcadia Holdings II Inc | Undefined | 0.5% |
| CareDx Inc | Health Care | 0.5% |
| ChemoCentryx Inc | Health Care | 0.5% |
| Stoke Therapeutics Inc | Health Care | 0.5% |
| Deciphera Pharmaceuticals Inc | Health Care | 0.5% |
| Central Garden & Pet Co. | Consumer Staples | 0.4% |
| I3 Verticals Inc | Information Technology | 0.4% |
| Coherus Biosciences, Inc. | Health Care | 0.4% |
| REVOLUTION Medicines Inc | Health Care | 0.4% |
| Telenav Inc | Information Technology | 0.4% |
| LiveXLive Media Inc | Communication Services | 0.3% |
| SI-BONE Inc | Health Care | 0.3% |
| Berkeley Lights Inc | Health Care | 0.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 08/31/2020
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
2.5%
|
|
| Real Estate |
1.0%
|
|
| Utilities | 0.0% | |
| Not Classified |
 1.1%
|
|
| Consumer Discretionary |
1.7%
|
|
| Consumer Staples |
1.5%
|
|
| Energy | 0.0% | |
| Financials |
0.9%
|
|
| Health Care |
3.2%
|
|
| Industrials |
2.5%
|
|
| Information Technology |
5.6%
|
|
| Materials | 0.0% |
Portfolio Details as of 08/31/2020
- Total Net Assets
- $100.15 M
- Number of Holdings
- 90
- Weighted Average Market Cap.
- 2.0 B
- P/B Ratio
- 6.3x
- P/E Ratio
- 25.9x
To view definitions for the above Portfolio Details, Click here.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
Contributors & Detractors as of 06/30/2020
Contributors
| Holding | Contribution |
|---|---|
| Fiverr Intl Ltd | 3.1% |
| Redfin Corp | 2.9% |
| Cerence Inc | 2.6% |
| Everquote Inc | 1.9% |
| Myovant Sciences Ltd | 1.7% |
Detractors
| Holding | Contribution |
|---|---|
| eHealth, Inc. | -0.7% |
| Nextcure Inc | -0.4% |
| 1-800-Flowers.com, Inc. | -0.2% |
| Aduro Biotech, Inc. | -0.1% |
| Eidos Therapeutics Inc | -0.1% |
% Contribution reflects the effect of the individual stock's performance on the Fund's overall performance for the period. Individual holdings and their effect on Fund performance may change significantly over time. Investors should consider the overall performance of the Fund before making a decision on whether or not to invest in the Fund.
Attribution Analysis
| Micro Cap Growth Fund | Benchmark | Variance | |||||
|---|---|---|---|---|---|---|---|
| Sector | Avg. Weight | Base Return | Avg. Weight | Base Return | Stock Selection | Group Weight | Total |
The total base return displayed for the Fund does not capture daily cash flow and trading activity and therefore is subject to reasonable variance from the Fund's actual return. Please refer to the Fund's performance results for longer-term returns. The Fund is actively managed and portfolio characteristics, such as individual holdings and sector weightings, may change significantly over time.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 09/30/2020
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 11/20/2001 | 11/21/2001 | 11/21/2001 | $0.00740 | $10.09 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/23/2020 | 11/24/2020 | 11/24/2020 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/20/2019 | 11/21/2019 | $2.3699 | - | $2.3699 | $12.12 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Upcoming Capital Gain Distribution
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date |
|---|---|
| 11/23/2020 | 11/24/2020 |
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 09/30/2020
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $18.47 |
| $50,000 to $99,999 | 4.75% | 4.00% | $18.28 |
| $100,000 to $249,999 | 3.95% | 3.25% | $18.13 |
| $250,000 to $499,999 | 2.75% | 2.25% | $17.90 |
| $500,000 to $999,999 | 1.95% | 1.75% | $17.76 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $17.41 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 08/31/2020
| 1.31% |
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
|
0Documents selected
|
Order | ||||
|---|---|---|---|---|---|
|
Summary Prospectus
Publish Date:11/03/2015
|
|||||
| n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
| n/a |
Prospectus (XBRL)
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
|||||
|
Annual Report
Publish Date:11/03/2015
|
|||||
|
Semi-Annual Report
Publish Date:11/03/2015
|
|||||
|
Fact Sheet
Publish Date:11/03/2015
|
|||||
|
Commentary
Publish Date:11/03/2015
|
|||||